Considerations for pre-clinical models and clinical trials of pluripotent stem cell-derived cardiomyocytes

[1]  Wei-Zhong Zhu,et al.  Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells. , 2013, Stem cells and development.

[2]  F. Müller,et al.  Reconsidering pluripotency tests: do we still need teratoma assays? , 2013, Stem cell research.

[3]  K. Cao,et al.  Intramyocardial Injection of Pig Pluripotent Stem Cells Improves Left Ventricular Function and Perfusion: A Study in a Porcine Model of Acute Myocardial Infarction , 2013, PloS one.

[4]  Richard T. Lee,et al.  Cardiac stem cell therapy and the promise of heart regeneration. , 2013, Cell stem cell.

[5]  K. Garber.  Inducing translation , 2013, Nature Biotechnology.

[6]  N. Rodrigues,et al.  Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells. , 2013, Cell stem cell.

[7]  L. Ye,et al.  Functional Consequences of Human Induced Pluripotent Stem Cell Therapy: Myocardial ATP Turnover Rate in the In Vivo Swine Heart With Postinfarction Remodeling , 2013, Circulation.

[8]  Udo Schumacher,et al.  Parthenogenetic stem cells for tissue-engineered heart repair. , 2013, The Journal of clinical investigation.

[9]  Joseph C. Wu,et al.  Immunogenicity of Pluripotent Stem Cells and Their Derivatives , 2013, Circulation research.

[10]  Y. Hoki,et al.  Negligible immunogenicity of terminally differentiated cells derived from induced pluripotent or embryonic stem cells , 2013, Nature.

[11]  A. Zeiher,et al.  Early cardiac retention of administered stem cells determines clinical efficacy of cell therapy in patients with dilated cardiomyopathy. , 2013, Circulation research.

[12]  M. Sever,et al.  Effects of Intracoronary CD34+ Stem Cell Transplantation in Nonischemic Dilated Cardiomyopathy Patients: 5-Year Follow-Up , 2013, Circulation research.

[13]  Wendy Y. Zhang,et al.  Genome Editing of Human Embryonic Stem Cells and Induced Pluripotent Stem Cells With Zinc Finger Nucleases for Cellular Imaging , 2012, Circulation research.

[14]  H. Calkins,et al.  Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCs , 2012, Nature.

[15]  Sean P. Palecek,et al.  Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling , 2012, Proceedings of the National Academy of Sciences.

[16]  K. Krause,et al.  Haplotype-based banking of human pluripotent stem cells for transplantation: potential and limitations. , 2012, Stem cells and development.

[17]  S. Schwartz,et al.  Embryonic stem cell trials for macular degeneration: a preliminary report , 2012, The Lancet.

[18]  B. Strulovici,et al.  Induced pluripotent stem cells — opportunities for disease modelling and drug discovery , 2011, Nature Reviews Drug Discovery.

[19]  Gordon Keller,et al.  SIRPA is a specific cell-surface marker for isolating cardiomyocytes derived from human pluripotent stem cells , 2011, Nature Biotechnology.

[20]  Thomas Rau,et al.  Human Engineered Heart Tissue as a Versatile Tool in Basic Research and Preclinical Toxicology , 2011, PloS one.

[21]  Shinya Yamanaka,et al.  Immunogenicity of induced pluripotent stem cells. , 2011, Circulation research.

[22]  J. Paavola,et al.  Small molecule Wnt inhibitors enhance the efficiency of BMP-4-directed cardiac differentiation of human pluripotent stem cells. , 2011, Journal of molecular and cellular cardiology.

[23]  Charles E. Murry,et al.  Growth of Engineered Human Myocardium With Mechanical Loading and Vascular Coculture , 2011, Circulation research.

[24]  R. Stewart,et al.  Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells , 2011, Nature.

[25]  E. Olson,et al.  Transient Regenerative Potential of the Neonatal Mouse Heart , 2011, Science.

[26]  G. Aquaro,et al.  Ferritin as a reporter gene for in vivo tracking of stem cells by 1.5-T cardiac MRI in a rat model of myocardial infarction. , 2011, American journal of physiology. Heart and circulatory physiology.

[27]  E. Kirkness,et al.  Somatic coding mutations in human induced pluripotent stem cells , 2011, Nature.

[28]  T. Okano,et al.  Composite Cell Sheets: A Further Step Toward Safe and Effective Myocardial Regeneration by Cardiac Progenitors Derived From Embryonic Stem Cells , 2010, Circulation.

[29]  Tomohiro Kono,et al.  Aberrant silencing of imprinted genes on chromosome 12qF1 in mouse induced pluripotent stem cells , 2010, Nature.

[30]  Chad A. Cowan,et al.  A purified population of multipotent cardiovascular progenitors derived from primate pluripotent stem cells engrafts in postmyocardial infarcted nonhuman primates. , 2010, The Journal of clinical investigation.

[31]  Eduardo Marbán,et al.  Assessment and Optimization of Cell Engraftment After Transplantation Into the Heart , 2010, Circulation research.

[32]  M. Zviman,et al.  Autologous mesenchymal stem cells produce reverse remodelling in chronic ischaemic cardiomyopathy. , 2009, European heart journal.

[33]  J. Karp,et al.  Death and Proliferation Time Course of Stem Cells Transplanted in the Myocardium , 2009, Molecular Imaging and Biology.

[34]  Sean P. Palecek,et al.  Functional Cardiomyocytes Derived From Human Induced Pluripotent Stem Cells , 2009, Circulation research.

[35]  Samuel Bernard,et al.  Evidence for Cardiomyocyte Renewal in Humans , 2008, Science.

[36]  Hideki Uosaki,et al.  Directed and Systematic Differentiation of Cardiovascular Cells From Mouse Induced Pluripotent Stem Cells , 2008, Circulation.

[37]  K. Plath,et al.  Reprogrammed Mouse Fibroblasts Differentiate into Cells of the Cardiovascular and Hematopoietic Lineages , 2008, Stem cells.

[38]  Eric D. Adler,et al.  Human cardiovascular progenitor cells develop from a KDR+ embryonic-stem-cell-derived population , 2008, Nature.

[39]  Heli Skottman,et al.  Good manufacturing practice and clinical-grade human embryonic stem cell lines. , 2008, Human molecular genetics.

[40]  Micha Drukker.  Recent advancements towards the derivation of immune-compatible patient-specific human embryonic stem cell lines. , 2008, Seminars in immunology.

[41]  N. Turovets,et al.  HLA homozygous stem cell lines derived from human parthenogenetic blastocysts. , 2008, Cloning and stem cells.

[42]  T. Ichisaka,et al.  Induction of Pluripotent Stem Cells from Adult Human Fibroblasts by Defined Factors , 2007, Cell.

[43]  T. Graf.  Faculty Opinions recommendation of Induction of pluripotent stem cells from adult human fibroblasts by defined factors. , 2007 .

[44]  P. Doevendans,et al.  Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. , 2007, Stem cell research.

[45]  Lila R Collins,et al.  Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts , 2007, Nature Biotechnology.

[46]  C. Ware,et al.  The FASEB Journal • Research Communication , 2007 .

[47]  K. Tokunaga,et al.  Human Leukocyte Antigen Matching Estimations in a Hypothetical Bank of Human Embryonic Stem Cell Lines in the Japanese Population for Use in Cell Transplantation Therapy , 2007, Stem cells.

[48]  George Q. Daley,et al.  Histocompatible Embryonic Stem Cells by Parthenogenesis , 2007, Science.

[49]  Chunhui Xu,et al.  Formation of human myocardium in the rat heart from human embryonic stem cells. , 2005, The American journal of pathology.

[50]  Larry Kedes,et al.  Washout of transplanted cells from the heart: a potential new hurdle for cell transplantation therapy. , 2005, Cardiovascular research.

[51]  Rona Shofti,et al.  Electromechanical integration of cardiomyocytes derived from human embryonic stem cells , 2004, Nature Biotechnology.

[52]  N. Benvenisty,et al.  The immunogenicity of human embryonic stem-derived cells. , 2004, Trends in biotechnology.

[53]  Chunhui Xu,et al.  Characterization and Enrichment of Cardiomyocytes Derived From Human Embryonic Stem Cells , 2002, Circulation research.

[54]  Maya Schuldiner,et al.  Characterization of the expression of MHC proteins in human embryonic stem cells , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[55]  J. Thomson,et al.  Surface antigens of human embryonic stem cells: changes upon differentiation in culture * , 2002, Journal of anatomy.

[56]  Doris A Taylor,et al.  Cellular cardiomyoplasty with autologous skeletal myoblasts for ischemic heart disease and heart failure , 2001, Current controlled trials in cardiovascular medicine.

[57]  K Walsh,et al.  Cardiomyocyte grafting for cardiac repair: graft cell death and anti-death strategies. , 2001, Journal of molecular and cellular cardiology.

[58]  J. Thomson,et al.  Embryonic stem cell lines derived from human blastocysts. , 1998, Science.

[59]  A. Nienhuis,et al.  Retrovirally marked CD34-enriched peripheral blood and bone marrow cells contribute to long-term engraftment after autologous transplantation. , 1995, Blood.

[60]  遠山 周吾.  Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes , 2013 .

[61]  M. Laflamme,et al.  Methods for the derivation and use of cardiomyocytes from human pluripotent stem cells. , 2011, Methods in molecular biology.

[62]  E. Sasaki,et al.  Nongenetic method for purifying stem cell–derived cardiomyocytes , 2010, Nature Methods.

[63]  Reflection paper on stem cell-based medicinal products , 2022 .